Trevi Therapeutics Inc (TRVI) Actualités

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates PR Newswire NEW...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024

Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November...

FNB Harvest annonce les distributions d’octobre 2024

Groupe de portefeuilles Harvest Inc. (« Harvest ») annonce les distributions suivantes pour les FNB Harvest pour le mois se terminant le 31...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough

Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough PR Newswire NEW...

Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences

Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences PR Newswire NEW HAVEN...

Form 8-K - Current report

Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program

Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program PR Newswire NEW HAVEN, Conn...

Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer

Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer PR...